Contact this trialFirst, we need to learn more about you.
Selective Inhibitor of Nuclear Export (SINE)
Selinexor for Solid Tumors
Recruiting1 awardPhase 2
Palo Alto, California
This trial tests if a drug can treat Wilms tumor, rhabdoid tumor, MPNST and other tumors with high XPO1 activity or genetic changes.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service